CRDF
Cardiff Oncology, Inc. Common Stock
stockNASDAQ
At CloseNov 3, 2026 3:59:57 PM EST
0.86USD+1.682%(+0.01)225,277
After-hoursNov 3, 2026 4:08:30 PM EST
0.889USD+3.553%(+0.031)
CRDF Financials
In Q2 FY 2026 (ended ), Cardiff Oncology, Inc. Common Stock (CRDF) reported revenue of $104K, net income of −$9.23M, operating cash flow of −$11.77M, and assets of $37.33M.
Loading financial statements…